Anita Tandle

Title: Anita Tandle: Innovator in Cancer Research

Introduction

Anita Tandle is a prominent inventor based in Towson, MD (US). She has made significant contributions to the field of cancer research, particularly through her innovative work on DOC1 polypeptides. With a total of 2 patents to her name, Tandle's inventions focus on methods to inhibit angiogenesis and tumor growth.

Latest Patents

Anita Tandle's latest patents include groundbreaking methods for cancer treatment. One patent details a purified DOC1 polypeptide comprising a fragment of SEQ ID NO:1, which is not the full-length DOC1 polypeptide sequence. This invention provides a method of inhibiting angiogenesis in a subject by administering a nucleic acid encoding a DOC1 polypeptide, allowing cells in the subject to produce the DOC1 polypeptide and thus inhibit angiogenesis. Additionally, another patent outlines a method for inhibiting tumor growth in a subject using a similar approach.

Career Highlights

Tandle works for the United States of America, as represented by the Secretary, Department of Health and Human Services. Her research has been pivotal in advancing therapeutic strategies for cancer treatment, showcasing her dedication to improving patient outcomes.

Collaborations

Anita has collaborated with notable colleagues in her field, including Steven K Libutti and Mijung Kwon. These partnerships have further enhanced her research and contributed to the development of her innovative patents.

Conclusion

Anita Tandle's work exemplifies the impact of innovation in cancer research. Her patents not only advance scientific understanding but also hold promise for future therapeutic applications.